Trial Profile
Multiple doses of ABT 267 +/- ritonavir in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2011
Price :
$35
*
At a glance
- Drugs Ombitasvir (Primary) ; Ritonavir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 03 Apr 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
- 01 Apr 2011 New trial record